Vanda Pharmaceuticals, a biopharmaceutical company based in Washington, DC, secured a win late last week when the US Court of Appeals for the Federal Circuit found a patent covering its schizophrenia drug to be patentable.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Vanda Pharmaceuticals, West-Ward Pharmaceuticals, Hikma, US Court of Appeals for the Federal Circuit, patent infringement